Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT05093894
Brief Summary:
Participants who are scheduled to have open ventral hernia repair (OVHR) will be asked to take part in this study.
The purpose of this study is to find out if placing Microlyte (which is a dissolvable sheet coated in silver) on the surgical incision is better than placing nothing on the surgical incision when it comes to decreasing the chance of surgical site infections.
The study device has been cleared by the Food and Drug Administration (FDA) for use on surgical incisions.
A total of 280 participants will be included in the study.
Participation will last for about 90 days.
Detailed Description:
The aim of our study is to assess the impact of Microlyte-AG® (Imbed Biosciences, Fitchburg, WI), a silver-coated bioabsorbable matrix, on surgical site infection (SSI) on patients undergoing clean open ventral hernia repair (OVHR) at Carolinas Medical Center/Atrium Health (Charlotte, NC), Prisma Health-Upstate (Greenville, SC), and Mission Health/HCA Healthcare (Asheville, NC).
Those who agree to participate in the study will undergo the following:
Information will be collected, including demographics, past medical and surgical history, and hospital outcomes.
On the day of surgery, participants will be "randomized" into one of the study groups listed below.
* Group 1: The study device will be cut into strips and placed in the surgical incision
* Group 2: Nothing will be placed in the surgical incision
For both groups, the surgical incision will then be closed with absorbable sutures, which is the usual treatment.
Participants will be seen by the study doctor 30 and 90 days after surgery for a checkup. At the 30-day visit, participants will have a physical examination, and the study doctor will check to see if any complications have happened since the last visit. The 90-day follow-up visit can be done in person or over the telephone and will be done to check and see if there have been any problems with the healing of the surgical incision.
Study:
NCT05093894
Study Brief:
Protocol Section:
NCT05093894